Photosensitization

Photosensitization in horses represents a condition in which skin becomes abnormally sensitive to ultraviolet light, resulting in severe dermatitis affecting non-pigmented or lightly pigmented skin areas exposed to sunlight. Unlike simple sunburn, which can affect any horse with prolonged intense sun exposure, photosensitization involves photodynamic agents that absorb ultraviolet energy and transfer it to surrounding tissues, causing cellular damage through reactive oxygen species production. This pathological process produces tissue injury far exceeding what normal sunlight exposure would cause, creating painful, sometimes severe skin lesions that can significantly affect horse welfare and require prompt veterinary intervention.

Photosensitization occurs worldwide in horses and is categorized into three main types based on the source of photodynamic agents. Type I (primary photosensitization) results from ingestion or contact with exogenous photodynamic compounds, often from specific plants. Type II (aberrant endogenous pigment synthesis) involves inherited defects in porphyrin metabolism producing endogenous photodynamic compounds; this type is rare in horses. Type III (hepatogenous or secondary photosensitization) is the most common form in horses and occurs when liver disease impairs phylloerythrin excretion, allowing this chlorophyll metabolite to accumulate and cause photosensitivity. Understanding the type of photosensitization is crucial for appropriate treatment and prevention.

The impact of photosensitization ranges from mild discomfort with limited skin changes to severe, debilitating disease with extensive tissue damage. Affected horses experience pain from sunburn-like lesions that can progress to vesiculation, ulceration, and skin sloughing in severe cases. The restriction to non-pigmented skin creates characteristic distribution patterns affecting white facial markings, leg markings, and any areas of pink skin. Severe cases may require extended stabling to prevent sun exposure, significantly impacting turnout and exercise routines. Hepatogenous photosensitization carries additional concerns because the underlying liver disease may be severe and potentially life-threatening independent of the skin manifestations.

Treatment success depends heavily on identifying and addressing the underlying cause while protecting affected horses from further sun exposure. Primary photosensitization often resolves once the offending plant or substance is removed from the horse's environment and skin lesions heal. Hepatogenous photosensitization prognosis depends largely on the nature and reversibility of the underlying liver disease. Early recognition of photosensitization signs allows prompt intervention that minimizes skin damage and enables timely investigation of potential liver involvement. Horse owners who understand the condition can implement immediate sun protection while awaiting veterinary evaluation, significantly improving outcomes.

Primary photosensitization results from exposure to photodynamic agents that reach the skin through ingestion or direct contact. Numerous plants contain photodynamic compounds capable of causing this condition. St. John's wort contains hypericin, a potent photosensitizer that affects horses grazing pastures where this plant grows. Buckwheat contains fagopyrin, which produces photosensitization in horses consuming significant quantities. Spring parsley, bishop's weed, and related plants contain furocoumarins that cause phototoxic reactions. Alsike clover causes a syndrome combining photosensitization with liver damage, representing an overlap between primary and hepatogenous types. Certain medications including phenothiazine-derived dewormers and some antibiotics can cause primary photosensitization in susceptible individuals. Contact photosensitization occurs when plants containing photodynamic compounds contact unpigmented skin directly.

Hepatogenous photosensitization, the most common type in horses, develops when liver dysfunction impairs phylloerythrin excretion. Phylloerythrin is a metabolite of chlorophyll produced by intestinal bacteria and normally removed from circulation by the liver for biliary excretion. When liver disease compromises this function, phylloerythrin accumulates in blood and tissues, reaching the skin where it absorbs ultraviolet light and initiates photodynamic damage. Any cause of significant liver disease can produce hepatogenous photosensitization, including pyrrolizidine alkaloid toxicity from plants like ragwort, groundsel, and fiddleneck. Alsike clover toxicity causes both liver damage and direct photosensitization. Aflatoxicosis from moldy feed, infectious hepatitis, and other liver diseases may produce secondary photosensitization.

Environmental and management factors significantly influence photosensitization occurrence and severity. Pasture composition determines exposure risk for primary photosensitization, with fields containing photodynamic plants posing greatest danger. Geographic location affects plant species present and solar radiation intensity. Season influences both plant growth patterns and sun exposure duration, with summer months presenting highest risk. Management practices including pasture maintenance, hay sourcing, and turnout scheduling affect exposure to causative agents. Feed storage conditions influence mycotoxin contamination risk that could produce hepatotoxicity and secondary photosensitization.

Risk factors predisposing horses to photosensitization include coat color patterns and management circumstances. Horses with extensive white markings or light pigmentation have more non-pigmented skin susceptible to photodynamic damage. Cremello, perlino, and other dilute color genetics producing pink skin over large body areas increase affected surface area when photosensitization occurs. Horses on pastures containing photodynamic plants face direct exposure risk. Those receiving certain medications known to cause photosensitization require sun protection during treatment. Horses with preexisting liver disease or concurrent conditions affecting liver function may be predisposed to hepatogenous photosensitization.

The pathophysiology of photosensitization involves photochemical reactions producing tissue damage. Photodynamic agents absorb ultraviolet light energy, particularly in the UVA range, and become excited to higher energy states. This absorbed energy transfers to molecular oxygen, producing reactive oxygen species including singlet oxygen and free radicals. These highly reactive molecules cause oxidative damage to cell membranes, proteins, and DNA, producing cell death and tissue inflammation. The damage is restricted to non-pigmented skin because melanin in pigmented areas absorbs ultraviolet light before it reaches photodynamic compounds, providing natural protection. The resulting tissue injury produces the characteristic painful dermatitis affecting only white or lightly pigmented skin areas.

Early warning signs of photosensitization may be subtle before obvious skin damage develops. Affected horses may show early restlessness or increased sensitivity when non-pigmented areas are touched. Initial erythema (redness) affecting pink skin may be difficult to appreciate but represents the earliest visible change. Horses may seek shade more than usual or seem uncomfortable in direct sunlight. White facial markings may appear slightly swollen or warm to touch before more obvious changes develop. Early behavioral signs including head shaking, rubbing white areas, or reluctance to go into sun-exposed areas should prompt closer examination of any non-pigmented skin. These early indicators provide opportunities for sun protection before severe damage occurs.

Common symptoms of established photosensitization create a characteristic clinical picture with predictable distribution. The hallmark finding is dermatitis strictly confined to non-pigmented or lightly pigmented skin while immediately adjacent pigmented areas remain completely normal. White facial markings, white leg markings, and any areas of pink skin show inflammation while surrounding dark skin appears unaffected. Affected areas develop erythema, edema, and pain to touch. The skin may feel warm and appear swollen. With progression, vesicles and bullae form, representing fluid accumulation in damaged skin. The sharp demarcation at pigment boundaries creates the classic photosensitization appearance that distinguishes this condition from other dermatological problems.

Behavioral changes accompanying photosensitization reflect significant discomfort from affected skin. Horses commonly exhibit pain responses when affected areas are touched, including flinching, moving away, or even defensive behaviors. Head shyness develops when facial markings are involved, complicating haltering and handling. Appetite may decrease secondary to pain, particularly if muzzle skin is affected. Horses with leg involvement may show reluctance to move or apparent lameness from painful skin over limbs. Seeking shade becomes pronounced, with horses refusing to leave covered areas even for feeding. Depression and decreased activity occur with severe or extensive involvement. Some horses become difficult to handle as pain affects tolerance for normal interactions.

Physical signs of photosensitization progress through recognizable stages of increasing severity. Mild cases show erythema and mild edema of non-pigmented skin that may resolve with sun protection. Moderate cases develop more pronounced swelling, vesicle formation, and serum exudation from damaged skin. Severe cases progress to extensive vesiculation, skin necrosis, and sloughing of affected areas. Crusting develops over damaged skin as serum and tissue fluid dry on the surface. Secondary bacterial infection may produce purulent discharge and increased swelling. The muzzle and face commonly show severe involvement due to sun exposure and lack of hair coverage. Coronary band involvement can affect hoof wall growth in severe, prolonged cases.

Symptom progression without intervention typically follows a predictable pattern of increasing damage. Initial erythema progresses to edema over hours of continued sun exposure. Vesiculation develops within twenty-four to forty-eight hours of significant exposure. Continued sun exposure produces skin necrosis and sloughing over several days. Secondary infection commonly complicates cases with extensive skin damage. In hepatogenous photosensitization, concurrent signs of liver disease including jaundice, weight loss, and behavioral changes may accompany or precede skin manifestations. With sun protection, mild cases stabilize within days, while severe cases may require weeks for initial healing with longer-term recovery of extensively damaged areas.

Emergency symptoms requiring immediate veterinary attention include signs suggesting severe photosensitization or significant underlying disease. Extensive skin sloughing affecting large body surface areas demands urgent care including fluid therapy and intensive wound management. Signs of systemic illness including fever, depression, and loss of appetite suggest either severe photosensitization consequences or significant underlying disease requiring investigation. Jaundice accompanying photosensitization indicates hepatogenous type with potentially serious liver involvement. Inability to eat or drink due to severe muzzle involvement creates nutritional emergency. Any horse showing rapid deterioration or signs of hepatic encephalopathy requires emergency evaluation.

Physical examination provides strong presumptive evidence for photosensitization diagnosis based on characteristic distribution pattern. The veterinarian will perform thorough inspection of all skin areas, documenting that lesions affect only non-pigmented areas while immediately adjacent pigmented skin remains normal. This strict distribution pattern essentially confirms photosensitization and distinguishes it from other dermatological conditions. Assessment of lesion severity guides treatment intensity, with evaluation of erythema, edema, vesiculation, necrosis, and infection. General physical examination assesses overall health status and looks for signs suggesting underlying disease, particularly hepatic involvement. Detailed history explores recent pasture access, plant exposures, medication administration, and potential toxin contacts.

Diagnostic testing focuses primarily on identifying the underlying cause and type of photosensitization rather than confirming the clinical diagnosis. Liver function testing through serum chemistry evaluation is essential for detecting hepatogenous photosensitization. Elevated gamma-glutamyltransferase (GGT), aspartate aminotransferase (AST), and bilirubin levels suggest hepatic involvement requiring further investigation. Bile acid measurements provide additional liver function information. Complete blood count may reveal changes suggesting chronic liver disease or infection. Urinalysis can detect bilirubin or other abnormalities related to liver dysfunction. Clotting time evaluation assesses hepatic synthetic function in suspected liver disease cases.

Advanced diagnostics help characterize liver involvement and identify specific causes in hepatogenous cases. Liver ultrasound evaluates hepatic architecture, detecting changes suggesting fibrosis, nodular disease, or other pathology. Liver biopsy provides definitive information about the type and severity of liver disease, often identifying specific causes such as pyrrolizidine alkaloid toxicity through characteristic histological changes. Fecal examination may detect plant material suggesting specific plant ingestion. Pasture evaluation by a knowledgeable individual identifies potentially causative plants in the horse's environment. Feed analysis can detect mycotoxins or other contaminants that might cause hepatotoxicity.

Differential diagnosis distinguishes photosensitization from other conditions affecting non-pigmented skin. Sunburn affects pink-skinned areas but occurs with normal sun exposure rather than photodynamic agent involvement, producing milder changes. Contact dermatitis may affect non-pigmented skin preferentially if the causative agent contacts those areas, but the distribution typically relates to contact pattern rather than strictly following pigment boundaries. Pemphigus foliaceus produces crusting skin disease that may involve white-skinned areas but does not show the strict pigment-based distribution. Bacterial or fungal infections may secondarily affect damaged photosensitized skin, requiring consideration in the differential. Vasculitis can produce skin lesions in dependent areas including white legs but typically shows different distribution patterns.

Immediate treatment for photosensitization centers on preventing further sun exposure while the underlying cause is identified and addressed. Complete removal from sunlight through stabling in a dark barn or application of full-coverage light-blocking sheets provides essential protection. Horses should remain out of direct sunlight until active lesions have healed and, for hepatogenous cases, until liver function has normalized. If immediate full stabling is impossible, providing access to deep shade and limiting turnout to nighttime hours reduces continued damage. Any suspected causative plants should be removed from the horse's environment, and suspect feeds should be discontinued pending investigation.

Medical management addresses skin inflammation and prevents secondary complications. Anti-inflammatory medications including non-steroidal anti-inflammatory drugs reduce pain and inflammation in damaged skin. Systemic corticosteroids may be used in severe cases for their potent anti-inflammatory effects, though potential hepatotoxicity concerns may limit use in hepatogenous cases. Topical treatments including soothing lotions, aloe vera preparations, or mild corticosteroid creams provide local relief for affected areas. Wound care for areas of skin sloughing includes gentle cleaning, application of antimicrobial preparations, and appropriate bandaging where feasible. Systemic antibiotics are indicated when secondary bacterial infection develops.

Treatment of underlying causes varies depending on photosensitization type. For primary photosensitization, removing the source of photodynamic compounds by eliminating access to causative plants or discontinuing implicated medications allows resolution once skin heals. Hepatogenous photosensitization requires treatment directed at the underlying liver disease when possible. Supportive care for liver disease includes appropriate nutrition, avoidance of further hepatotoxic exposures, and medications to support liver function where indicated. Some causes of hepatogenous photosensitization, such as pyrrolizidine alkaloid toxicity, produce irreversible liver damage with guarded prognosis regardless of skin care.

Supportive care addresses complications and supports recovery. Fluid therapy maintains hydration, particularly important when extensive skin damage causes significant fluid losses. Nutritional support ensures adequate caloric intake, which may require dietary modifications if facial lesions affect eating comfort. Pain management beyond anti-inflammatory medication may include additional analgesics for severe cases. Eye protection may be needed if periocular skin is severely affected. Fly control prevents insect irritation of damaged skin. Environmental management maintains clean, dust-free conditions that minimize irritation and infection risk.

Long-term management prevents recurrence and addresses any residual liver disease. Permanent removal of causative plants from pastures prevents primary photosensitization recurrence. Ongoing sun protection through turnout scheduling or physical barriers protects horses with persistent photosensitivity or those prone to recurrence. Horses with hepatogenous photosensitization require ongoing liver function monitoring to assess recovery or progression of underlying disease. Dietary modifications may support liver health long-term. Careful feed sourcing avoids mycotoxin exposure that could cause additional liver damage.

Treatment decision factors influence management approach selection. Photosensitization type significantly affects prognosis and treatment intensity, with primary cases generally having better outcomes than hepatogenous cases with significant liver damage. Severity of skin involvement guides intensity of wound care and supportive measures. Underlying cause identification affects treatment planning and long-term prognosis. Horse use and value influence willingness to pursue aggressive treatment and diagnostics. Cost considerations factor into decision-making, particularly for horses with hepatogenous photosensitization requiring extensive liver evaluation and potentially lengthy treatment.

Recovery timelines for photosensitization vary widely depending on type, severity, and underlying cause. Mild primary photosensitization with limited skin involvement may show significant improvement within one to two weeks of sun protection and causative agent removal. More severe skin damage requires longer healing times, with areas of skin sloughing potentially taking four to six weeks for initial healing and months for complete hair regrowth. Hepatogenous photosensitization recovery depends largely on the underlying liver disease; reversible causes may allow full recovery over weeks to months, while irreversible liver damage may result in chronic photosensitivity or progressive hepatic failure. Skin changes often resolve before underlying liver function normalizes, requiring continued sun protection beyond apparent skin healing.

Post-treatment care and monitoring ensure complete recovery while watching for complications or recurrence. Skin condition assessment tracks healing progress and detects secondary infection early. For hepatogenous cases, serial liver function testing documents improvement or identifies progressive disease requiring treatment adjustment. Gradual sun exposure reintroduction occurs only after complete skin healing and, for hepatogenous cases, normalization of liver parameters. Initial reintroduction should be brief and supervised, with close monitoring for any sign of recurrence. Long-term pasture management prevents re-exposure to causative plants.

Prognosis factors significantly influence expected outcomes. Photosensitization type is the most important determinant, with primary photosensitization carrying excellent prognosis for full recovery when the causative agent is identified and removed. Hepatogenous photosensitization prognosis depends entirely on the nature of underlying liver disease. Pyrrolizidine alkaloid toxicity typically causes progressive, irreversible liver damage with guarded to poor long-term prognosis despite possible initial improvement. Other liver diseases may be more amenable to treatment with better outcomes. Severity of skin damage affects recovery timeline but typically not ultimate outcome for skin healing. Concurrent complications including secondary infection or systemic illness worsen short-term prognosis.

Long-term outlook varies with photosensitization type and treatment success. Horses recovering from primary photosensitization typically return to full normal function with appropriate management preventing re-exposure. Some residual skin changes including scarring or pigment alterations may persist in areas of severe damage but are primarily cosmetic concerns. Horses with hepatogenous photosensitization from reversible liver disease may recover fully with permanent precautions against future hepatotoxin exposure. Those with progressive liver disease face declining prognosis despite skin management. Long-term sun protection may be necessary for horses with chronic or recurrent photosensitivity. Quality of life considerations guide ongoing management decisions, particularly for horses with irreversible liver disease.

Management practices for preventing photosensitization focus on avoiding causative agents and protecting susceptible skin. Pasture management eliminates or controls photodynamic plants through mowing, herbicide application, or pasture renovation. Regular pasture inspection identifies problem plants before horses consume them. Providing adequate quality forage reduces grazing of less palatable but potentially toxic plants. Feed sourcing from reputable suppliers minimizes mycotoxin contamination risk. Proper feed storage prevents mold growth that could produce hepatotoxic compounds. Careful medication selection considers photosensitization potential, with appropriate sun protection during treatment with known photosensitizing drugs.

Nutritional approaches support liver health and reduce hepatogenous photosensitization risk. Balanced nutrition maintains overall health and normal hepatic function. Avoiding known hepatotoxic substances including certain plants and contaminated feeds protects liver function. Adequate protein intake supports liver regeneration capacity. Antioxidant supplementation may provide modest liver protection, though evidence specifically for photosensitization prevention is limited. Maintaining appropriate body condition prevents the metabolic stress that can compromise liver function.

Environmental modifications reduce both causative agent exposure and sun exposure for susceptible horses. Physical removal of photodynamic plants from pastures and fence lines eliminates direct exposure risk. Rotational grazing reduces plant selection pressure that might force horses to eat less palatable toxic species. Providing shelter access allows horses to self-protect from intense sun exposure. Strategic turnout scheduling limits sun exposure during peak intensity hours. Fly sheets and masks providing UV protection reduce sun exposure for horses that must be outside during daylight hours.

Sun protection measures specifically prevent photosensitization in at-risk horses. UV-blocking fly sheets and masks protect non-pigmented skin during necessary sun exposure. Zinc oxide or similar sun-blocking preparations applied to pink-skinned areas provide topical protection. Limiting turnout to early morning, evening, and nighttime hours reduces sun exposure intensity. Ensuring shade access in all turnout areas allows horses to avoid direct sun. For horses with known photosensitivity or during treatment with photosensitizing medications, complete sun avoidance through stabling may be necessary.

Veterinary care components supporting prevention include prompt attention to any liver abnormalities that might predispose to photosensitization. Regular health monitoring detects early liver function changes before photosensitization develops. Appropriate treatment of any identified liver disease minimizes phylloerythrin accumulation. Drug selection considers photosensitization potential when prescribing for horses with extensive white markings or those in high-sun environments. Education about photosensitization risk factors helps owners implement appropriate preventive measures.

Daily management adjustments for horses with photosensitization or photosensitization risk integrate sun protection into routine care. Turnout scheduling for susceptible horses ideally limits sun exposure to dawn, dusk, and nighttime when ultraviolet intensity is minimal. When daytime turnout is necessary, ensuring accessible shade and applying protective equipment reduces risk. Daily inspection of non-pigmented skin areas detects early changes requiring intervention. For horses with active or healing photosensitization, gentle wound care maintains lesion hygiene without causing additional trauma. Medication administration schedules consider photosensitizing potential of any treatments. Documentation of sun exposure and skin condition helps identify patterns guiding management adjustments.

Housing and turnout considerations for photosensitization-prone horses emphasize sun protection while maintaining quality of life. Ideal facilities include well-ventilated barns providing complete sun protection for daytime stabling and safe nighttime turnout options. Shelter structures in pastures should provide deep shade adequate for horses to fully protect non-pigmented areas. Turnout companions should be compatible with restricted schedules and space requirements. Pasture selection avoids fields containing known photodynamic plants. Run-in shed placement ensures shade availability throughout daylight hours as sun position changes. For horses with hepatogenous photosensitization, reducing stress through comfortable, consistent housing supports liver recovery.

Exercise modifications accommodate sun protection needs while maintaining fitness. Scheduling riding and training for early morning or evening hours avoids peak sun exposure. Indoor arena availability allows midday exercise when necessary. Trail riding route selection considers shade availability along the route. Application of UV-protective equipment during outdoor exercise reduces skin exposure. For horses with active lesions, exercise intensity may need reduction to avoid exacerbating inflammation or causing wound trauma. Post-exercise care includes skin inspection and wound care as needed.

Monitoring and ongoing care track photosensitization status and prevention effectiveness. Regular skin inspection of non-pigmented areas detects early changes before significant damage develops. For horses with hepatogenous photosensitization history, periodic liver function monitoring detects recurring or progressive liver disease. Environmental monitoring ensures pastures remain free of photodynamic plants through seasonal inspections. Feed quality assessment prevents exposure to contaminated or moldy feeds. Weather and season awareness guides adjustment of protective measures as sun intensity varies. Communication with veterinarians about any concerns allows prompt intervention when needed.

Quality of life considerations guide ongoing management decisions for photosensitization-prone horses. Most horses with appropriate sun protection lead full, comfortable lives despite photosensitivity risk. Turnout restrictions may reduce pasture time but nighttime turnout often provides adequate outdoor access. Management requirements vary with individual risk level, with some horses needing only modest precautions while others require intensive sun avoidance. For horses with progressive liver disease causing chronic photosensitization, quality of life assessments guide decisions about continued management versus humane euthanasia when suffering cannot be adequately controlled.

Breed predisposition for photosensitization relates primarily to coat color patterns rather than breed-specific disease susceptibility. Horses with extensive white markings have more non-pigmented skin surface area at risk when photosensitization occurs. Paint horses and Pintos with large white areas face increased potential impact compared to horses with minimal white markings. Appaloosas, particularly those with extensive white blanket patterns, have significant at-risk skin areas. Cremello, perlino, and smoky cream horses with pink skin over most or all of their bodies face the greatest potential surface area involvement. White or gray horses may have varying amounts of pigmented versus non-pigmented skin depending on individual characteristics.

Draft breeds including Clydesdales, Shires, and Belgians commonly display extensive white leg markings (feathering areas) and facial markings that increase photosensitization visibility and impact. The feathered lower legs of these breeds may provide some sun protection for underlying pink skin, but severe photosensitization can still occur. American breeds including Quarter Horses, Paints, and Appaloosas vary widely in white marking extent, with individual assessment more valuable than breed generalizations. Arabian horses typically have limited white markings, reducing photosensitization surface area, but those with significant white remain susceptible.

Breed does not influence susceptibility to the underlying causes of photosensitization, only the extent of visible and clinically significant skin involvement when photosensitization occurs. Any horse exposed to photodynamic plants or developing hepatogenous photosensitization will experience damage to whatever non-pigmented skin they possess. Breeding specifically to reduce white markings is not practiced for photosensitization prevention purposes, as management approaches effectively control the condition in most cases. Selection considerations focus on intended use and overall characteristics rather than photosensitization risk. However, owners of extensively white-marked horses should understand increased management requirements in environments where photosensitization risk exists.

Several conditions commonly co-occur with photosensitization or develop as complications. Hepatogenous photosensitization by definition occurs with liver disease, and the underlying hepatic condition often represents the more serious health concern. Pyrrolizidine alkaloid toxicity causes progressive liver fibrosis that may continue advancing despite sun protection controlling skin manifestations. Secondary bacterial skin infections complicate areas of damaged skin, requiring concurrent antibiotic therapy. Corneal damage may occur if periocular skin involvement affects eye protection. Hoof wall abnormalities can develop if coronary band damage persists, producing growth defects.

Conditions producing symptoms similar to photosensitization require differentiation. Simple sunburn affects pink-skinned areas but results from direct ultraviolet damage without photodynamic agents, typically producing milder lesions. Contact dermatitis may preferentially affect non-pigmented skin if the irritant contacts those areas but does not show strict pigment-boundary distribution. Pemphigus foliaceus produces crusting skin disease that may involve white areas but also affects pigmented skin and shows different histological changes. Vasculitis can cause skin lesions on white legs but typically produces different lesion morphology and does not strictly follow pigment boundaries. Drug eruption may produce skin changes requiring differentiation from drug-induced photosensitization.

Potential complications of photosensitization extend beyond immediate skin damage. Severe cases with extensive skin loss face fluid and protein losses similar to burn patients, requiring intensive supportive care. Secondary infections of damaged skin can become systemic in severe or immunocompromised cases. Permanent scarring and pigment changes may affect appearance in areas of severe damage. Chronic or recurrent photosensitization causes ongoing management challenges and lifestyle limitations. For hepatogenous cases, progressive liver disease may lead to hepatic failure, hepatic encephalopathy, and death independent of skin manifestations. Psychological effects including sun aversion and handling difficulties may develop in horses experiencing significant pain from photosensitization episodes.